Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Qiangxin Tang (Yiqi Qiangxin Decoction) is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of chronic heart failure. It is designed to tonify qi and strengthen the heart, addressing the TCM syndrome of Qi deficiency and blood stasis often associated with cardiac dysfunction. Clinical research, such as trials conducted at Dongzhimen Hospital (affiliated with Beijing University of Chinese Medicine), evaluates its efficacy in patients with heart failure with mildly reduced ejection fraction (HFmrEF) and chronic heart failure. The formula typically aims to improve cardiac function, exercise tolerance, and quality of life by modulating neurohumoral factors and improving myocardial energy metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yiqi qiangxin tang.